Inovio Pharmaceuticals Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Abrdn Physical Platinum Shares ETF trades at $16.16. The key difference: Abrdn Physical Platinum Shares ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | PPLT | |
|---|---|---|
Market Cap | $78.55M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $2.87 | $25.23 |
52-Week Low | $0.66 | $11.95 |
Enterprise Value | $49.56M | — |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →